01.Breakthrough drug trial points to positive news for alopecia sufferers
sThere is positive news for people suffering from the hair loss ailment alopecia as results show total hair regrowth for affected participants in an unrelated drug trial.
The trial conducted in the USA, using a drug normally prescribed for a bone marrow condition, resulted in total hair regrowth in all three of the patients participating who had experienced hair loss as a result of alopecia.
The results, published in the online edition of the journal Nature Medicine, were conducted by a team of scientists treating the trial participants with the drug ruxolitinib, which is approved in the US and EU for the treatment of bone marrow disorder myelofibrosis. The trial participants took two tablets a day and experienced full hair regrowth after four to five months.
Alopecia areata is a common autoimmune condition where the body attacks its own hair follicles and causes the hair to fall out on the scalp and body. It is not life threatening, but can cause severe psychological and emotional distress. There are three types of alopecia areata: alopecia areata, alopecia areata totalis and alopecia areata universalis.
For more details on the study, see the Nature Medicine article abstract.